滄州大化(600230.SH):年產10萬噸聚碳酸酯項目投產
格隆匯 12 月 28日丨滄州大化(600230.SH)公佈,公司年產10萬噸聚碳酸酯(PC)項目,於近日投產,產出合格產品。
該項目是河北省及滄州市重點建設項目,位於河北省滄州市臨港化工園區,佔地366,766.35平方米(摺合約550畝),設計產能為年產10萬噸,生產工藝為光氣界面壓縮法。聚碳酸酯是一種綜合性能非常優異的熱塑性工程塑料,被廣泛應用於汽車零部件製造、消費電子、電子工程、家用電器、發光二極管(LED)照明、建築板材、耐用消費品、光學透鏡、光盤基料以及專用防護和醫療器械等諸多領域。
此次項目投產後有利於充分發揮公司在光氣系列產品生產方面的優勢、擴大光氣化產品種類,提高企業抗風險能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.